Mel Herbert CT rant

Mel Herbert of EMRAP and Essentials of EM fame – virtually attended the ‘carbon’-neutral‘ section of the recent WA ACEM 2012 conference

Mel delivers another inimitable rant on CTA, chest pain and the ability to discharge low risk patients with chest pain from the ED

[blackbirdpie url=”https://twitter.com/Eleytherius/status/211351001268109312″]

[blackbirdpie url=”https://twitter.com/scanman/status/211363791408082944″]

[blackbirdpie url=”https://twitter.com/gruntdoc/status/211354554019749888″]

[blackbirdpie url=”https://twitter.com/peterallely/status/211352128281780224″]

 

Print Friendly

Comments

  1. says

    CCTA certainly has promise = it has similar accuracy to stress, with faster throughput time and likely lower radiation. but as dr. herbert touches on, the problem is with specificity. CCTA will find a lot of small plaques, i.e. there will be a lot of “non-negative” studies, that will probably result in further stress tests & PCI. add into that the overtesting that he mentions as well (how many low-risk chest pain patients are going to get CCTAs now?) and we might be shooting ourselves in the foot (or, irradiating our patients in the thyroid)

Comments